Columbia University

Technology Ventures

EpiBone

EpiBone: Founded out of the lab of Dr. Gordana Vunjak-Novakovic and led by Co-Founder and CEO, Dr. Nina Tandon, EpiBone is a privately-held regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of a patient’s own cells to create living solutions that become a seamless part of a patient’s body. EpiBone is currently developing a pipeline of bone, cartilage, and osteochondral (bone and cartilage) products. The company recently received FDA clearance for its IND, to begin their first-in-human clinical trial using their bone product, EB-CMF.

To learn more about this opportunity, contact:

Beth Kauderer
Technology Licensing Officer
beth.kauderer@columbia.edu